Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
14
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Douglas James Michael | Chief Financial Officer | 8 | $50.0K | $0 | 2023-12-13 |
| Ross Jeffrey James | Chief Executive Officer | 27 | $50.0K | $0 | 2023-12-13 |
| Heine Lisa Wipperman | Director | 7 | $50.0K | $0 | 2023-12-13 |
| Burke William P. Mr. | Director | 7 | $50.0K | $0 | 2023-12-13 |
| Maag Peter | Director | 7 | $50.0K | $0 | 2023-12-13 |
| BUCKMAN PAUL | Director | 13 | $50.0K | $0 | 2023-12-13 |
| ERB JOHN L | Director | 13 | $50.0K | $0 | 2023-12-13 |
| Barry John Joseph | Vice President of R&D | 9 | $10.0K | $0 | 2023-03-10 |
| Kattungal Laji | Vice President of Quality | 3 | $0 | $0 | 2022-01-13 |
| NIEBUR BRIAN | Chief Financial Officer | 9 | $0 | $0 | 2022-01-13 |
| DAVITA INC. | 10% Owner | 9 | $0 | $0 | 2021-06-28 |
| WAGNER MARK T | Director | 2 | $0 | $0 | 2021-06-28 |
| EIBENSTEINER RONALD E | Director | 6 | $0 | $0 | 2021-06-28 |
| BAXTER HEALTHCARE CORP | 10% Owner | 2 | $0 | $0 | 2021-06-24 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Ross Jeffrey James | CHIEF EXECUTIVE OFFICER | D To issuer deriv | 2023-12-13 | 2023-12-13 | 1,500 | — | $0 | 0 | SEC↗ |
| Ross Jeffrey James | CHIEF EXECUTIVE OFFICER | D To issuer deriv | 2023-12-13 | 2023-12-13 | 41,250 | — | $0 | 0 | SEC↗ |
| Ross Jeffrey James | CHIEF EXECUTIVE OFFICER | D To issuer deriv | 2023-12-13 | 2023-12-13 | 43,750 | — | $0 | 0 | SEC↗ |
| Ross Jeffrey James | CHIEF EXECUTIVE OFFICER | D To issuer deriv | 2023-12-13 | 2023-12-13 | 33,688 | — | $0 | 0 | SEC↗ |
| Ross Jeffrey James | CHIEF EXECUTIVE OFFICER | D To issuer deriv | 2023-12-13 | 2023-12-13 | 39,375 | — | $0 | 0 | SEC↗ |
| Ross Jeffrey James | CHIEF EXECUTIVE OFFICER | D To issuer deriv | 2023-12-13 | 2023-12-13 | 100,000 | — | $0 | 0 | SEC↗ |
| Ross Jeffrey James | CHIEF EXECUTIVE OFFICER | D To issuer deriv | 2023-12-13 | 2023-12-13 | 68,714 | — | $0 | 0 | SEC↗ |
| Ross Jeffrey James | CHIEF EXECUTIVE OFFICER | D To issuer deriv | 2023-12-13 | 2023-12-13 | 100,000 | — | $0 | 0 | SEC↗ |
| Ross Jeffrey James | CHIEF EXECUTIVE OFFICER | D To issuer deriv | 2023-12-13 | 2023-12-13 | 100,000 | — | $0 | 0 | SEC↗ |
| Douglas James Michael | CHIEF FINANCIAL OFFICER | D To issuer deriv | 2023-12-13 | 2023-12-13 | 180,000 | — | $0 | 0 | SEC↗ |
| Douglas James Michael | CHIEF FINANCIAL OFFICER | D To issuer deriv | 2023-12-13 | 2023-12-13 | 40,000 | — | $0 | 0 | SEC↗ |
| BUCKMAN PAUL | Director | D To issuer deriv | 2023-12-13 | 2023-12-13 | 100,000 | — | $0 | 0 | SEC↗ |
| BUCKMAN PAUL | Director | D To issuer deriv | 2023-12-13 | 2023-12-13 | 18,750 | — | $0 | 0 | SEC↗ |
| BUCKMAN PAUL | Director | D To issuer deriv | 2023-12-13 | 2023-12-13 | 25,000 | — | $0 | 0 | SEC↗ |
| BUCKMAN PAUL | Director | D To issuer deriv | 2023-12-13 | 2023-12-13 | 25,000 | — | $0 | 0 | SEC↗ |
| BUCKMAN PAUL | Director | D To issuer deriv | 2023-12-13 | 2023-12-13 | 25,000 | — | $0 | 0 | SEC↗ |
| ERB JOHN L | Director | D To issuer deriv | 2023-12-13 | 2023-12-13 | 25,000 | — | $0 | 0 | SEC↗ |
| ERB JOHN L | Director | D To issuer deriv | 2023-12-13 | 2023-12-13 | 25,000 | — | $0 | 0 | SEC↗ |
| ERB JOHN L | Director | D To issuer deriv | 2023-12-13 | 2023-12-13 | 25,000 | — | $0 | 0 | SEC↗ |
| ERB JOHN L | Director | D To issuer deriv | 2023-12-13 | 2023-12-13 | 18,750 | — | $0 | 0 | SEC↗ |
| ERB JOHN L | Director | D To issuer deriv | 2023-12-13 | 2023-12-13 | 100,000 | — | $0 | 0 | SEC↗ |
| Ross Jeffrey James | CHIEF EXECUTIVE OFFICER | D To issuer | 2023-12-13 | 2023-12-13 | 87,500 | — | $0 | 0 | SEC↗ |
| Douglas James Michael | CHIEF FINANCIAL OFFICER | D To issuer | 2023-12-13 | 2023-12-13 | 20,000 | — | $0 | 0 | SEC↗ |
| Burke William P. Mr. | Director | D To issuer | 2023-12-13 | 2023-12-13 | 67,413 | — | $0 | 0 | SEC↗ |
| BUCKMAN PAUL | Director | D To issuer | 2023-12-13 | 2023-12-13 | 54,201 | — | $0 | 0 | SEC↗ |
| ERB JOHN L | Director | D To issuer | 2023-12-13 | 2023-12-13 | 54,201 | — | $0 | 0 | SEC↗ |
| Maag Peter | Director | D To issuer | 2023-12-13 | 2023-12-13 | 58,368 | — | $0 | 0 | SEC↗ |
| Heine Lisa Wipperman | Director | D To issuer | 2023-12-13 | 2023-12-13 | 67,413 | — | $0 | 0 | SEC↗ |
| Ross Jeffrey James | CHIEF EXECUTIVE OFFICER | U Tender | 2023-12-12 | 2023-12-13 | 308,775 | — | $0 | 87,500 | SEC↗ |
| Douglas James Michael | CHIEF FINANCIAL OFFICER | U Tender | 2023-12-12 | 2023-12-13 | 31,250 | — | $0 | 20,000 | SEC↗ |
| Burke William P. Mr. | Director | U Tender | 2023-12-12 | 2023-12-13 | 66,943 | — | $0 | 67,413 | SEC↗ |
| BUCKMAN PAUL | Director | U Tender | 2023-12-12 | 2023-12-13 | 52,593 | — | $0 | 54,201 | SEC↗ |
| ERB JOHN L | Director | U Tender | 2023-12-12 | 2023-12-13 | 56,260 | — | $0 | 54,201 | SEC↗ |
| Maag Peter | Director | U Tender | 2023-12-12 | 2023-12-13 | 62,092 | — | $0 | 58,368 | SEC↗ |
| Heine Lisa Wipperman | Director | U Tender | 2023-12-12 | 2023-12-13 | 66,943 | — | $0 | 67,413 | SEC↗ |
| ERB JOHN L | Director | A Award | 2023-06-01 | 2023-06-05 | 54,201 | — | $0 | 110,461 | SEC↗ |
| Maag Peter | Director | A Award | 2023-06-01 | 2023-06-05 | 54,201 | — | $0 | 120,460 | SEC↗ |
| BUCKMAN PAUL | Director | A Award | 2023-06-01 | 2023-06-05 | 54,201 | — | $0 | 106,794 | SEC↗ |
| Burke William P. Mr. | Director | A Award | 2023-06-01 | 2023-06-05 | 54,201 | — | $0 | 134,356 | SEC↗ |
| Heine Lisa Wipperman | Director | A Award | 2023-06-01 | 2023-06-05 | 54,201 | — | $0 | 134,356 | SEC↗ |
| Heine Lisa Wipperman | Director | P Buy | 2023-03-10 | 2023-03-30 | 31,250 | $1.60 | $50.0K | 80,155 | SEC↗ |
| Burke William P. Mr. | Director | P Buy | 2023-03-10 | 2023-03-30 | 31,250 | $1.60 | $50.0K | 80,155 | SEC↗ |
| ERB JOHN L | Director | P Buy | 2023-03-10 | 2023-03-30 | 31,250 | $1.60 | $50.0K | 56,260 | SEC↗ |
| Maag Peter | Director | P Buy | 2023-03-10 | 2023-03-30 | 31,250 | $1.60 | $50.0K | 66,259 | SEC↗ |
| BUCKMAN PAUL | Director | P Buy | 2023-03-10 | 2023-03-30 | 31,250 | $1.60 | $50.0K | 52,593 | SEC↗ |
| Barry John Joseph | VICE PRESIDENT OF R&D | P Buy | 2023-03-10 | 2023-03-30 | 6,250 | $1.60 | $10.0K | 35,485 | SEC↗ |
| Ross Jeffrey James | CHIEF EXECUTIVE OFFICER | P Buy | 2023-03-10 | 2023-03-30 | 31,250 | $1.60 | $50.0K | 396,276 | SEC↗ |
| Douglas James Michael | CHIEF FINANCIAL OFFICER | P Buy | 2023-03-10 | 2023-03-30 | 31,250 | $1.60 | $50.0K | 51,250 | SEC↗ |
| Douglas James Michael | CHIEF FINANCIAL OFFICER | A Award deriv | 2023-01-13 | 2023-01-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Barry John Joseph | VICE PRESIDENT OF R&D | A Award deriv | 2023-01-13 | 2023-01-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Ross Jeffrey James | CHIEF EXECUTIVE OFFICER | A Award deriv | 2023-01-13 | 2023-01-18 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Douglas James Michael | CHIEF FINANCIAL OFFICER | A Award | 2023-01-13 | 2023-01-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Barry John Joseph | VICE PRESIDENT OF R&D | A Award | 2023-01-13 | 2023-01-18 | 10,000 | — | $0 | 29,235 | SEC↗ |
| Ross Jeffrey James | CHIEF EXECUTIVE OFFICER | A Award | 2023-01-13 | 2023-01-18 | 50,000 | — | $0 | 369,513 | SEC↗ |
| Ross Jeffrey James | CHIEF EXECUTIVE OFFICER | F Tax w/h | 2023-01-13 | 2023-01-18 | 4,487 | $3.26 | $14.6K | 365,026 | SEC↗ |
| Ross Jeffrey James | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2022-12-06 | 2022-12-08 | 37,500 | — | $0 | 0 | SEC↗ |
| Ross Jeffrey James | CHIEF EXECUTIVE OFFICER | M Exercise | 2022-12-06 | 2022-12-08 | 37,500 | $1.25 | $46.9K | 331,088 | SEC↗ |
| Ross Jeffrey James | CHIEF EXECUTIVE OFFICER | F Tax w/h | 2022-12-06 | 2022-12-08 | 11,575 | $4.05 | $46.9K | 319,513 | SEC↗ |
| Barry John Joseph | VICE PRESIDENT OF R&D | F Tax w/h | 2022-10-01 | 2022-10-04 | 765 | $4.38 | $3.4K | 19,235 | SEC↗ |
| ERB JOHN L | Director | A Award | 2022-08-10 | 2022-08-16 | 12,788 | — | $0 | 25,010 | SEC↗ |
| Burke William P. Mr. | Director | A Award | 2022-08-10 | 2022-08-16 | 12,788 | — | $0 | 48,905 | SEC↗ |
| Heine Lisa Wipperman | Director | A Award | 2022-08-10 | 2022-08-16 | 12,788 | — | $0 | 48,905 | SEC↗ |
| Maag Peter | Director | A Award | 2022-08-10 | 2022-08-16 | 12,788 | — | $0 | 35,009 | SEC↗ |
| BUCKMAN PAUL | Director | A Award | 2022-08-10 | 2022-08-16 | 12,788 | — | $0 | 21,343 | SEC↗ |
| Ross Jeffrey James | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2022-03-15 | 2022-03-17 | 35,438 | — | $0 | 0 | SEC↗ |
| Ross Jeffrey James | CHIEF EXECUTIVE OFFICER | M Exercise | 2022-03-15 | 2022-03-17 | 35,438 | $1.25 | $44.3K | 293,588 | SEC↗ |
| Douglas James Michael | Chief Financial Officer | A Award deriv | 2022-03-01 | 2022-03-02 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Ross Jeffrey James | CHIEF EXECUTIVE OFFICER | A Award deriv | 2022-01-13 | 2022-01-18 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Kattungal Laji | VICE PRESIDENT OF QUALITY | A Award deriv | 2022-01-13 | 2022-01-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Barry John Joseph | VICE PRESIDENT OF R&D | A Award deriv | 2022-01-13 | 2022-01-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NIEBUR BRIAN | CHIEF FINANCIAL OFFICER | A Award deriv | 2022-01-13 | 2022-01-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Ross Jeffrey James | CHIEF EXECUTIVE OFFICER | A Award | 2022-01-13 | 2022-01-18 | 50,000 | — | $0 | 258,150 | SEC↗ |
| Kattungal Laji | VICE PRESIDENT OF QUALITY | A Award | 2022-01-13 | 2022-01-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Barry John Joseph | VICE PRESIDENT OF R&D | A Award | 2022-01-13 | 2022-01-18 | 10,000 | — | $0 | 20,000 | SEC↗ |
| NIEBUR BRIAN | CHIEF FINANCIAL OFFICER | A Award | 2022-01-13 | 2022-01-18 | 10,000 | — | $0 | 24,668 | SEC↗ |
| Barry John Joseph | Vice President of R&D | A Award deriv | 2022-01-03 | 2022-01-05 | 1,500 | — | $0 | 1,500 | SEC↗ |
| NIEBUR BRIAN | Chief Financial Officer | A Award deriv | 2022-01-03 | 2022-01-05 | 1,500 | — | $0 | 1,500 | SEC↗ |
| Kattungal Laji | Vice President of Quality | A Award deriv | 2022-01-03 | 2022-01-05 | 1,500 | — | $0 | 1,500 | SEC↗ |
| Ross Jeffrey James | Chief Executive Officer | A Award deriv | 2022-01-03 | 2022-01-05 | 1,500 | — | $0 | 1,500 | SEC↗ |
| Burke William P. Mr. | Director | A Award | 2022-01-03 | 2022-01-05 | 31,712 | — | $0 | 36,117 | SEC↗ |
| Burke William P. Mr. | Director | A Award | 2022-01-03 | 2022-01-05 | 4,405 | — | $0 | 4,405 | SEC↗ |
| Heine Lisa Wipperman | Director | A Award | 2022-01-03 | 2022-01-05 | 4,405 | — | $0 | 4,405 | SEC↗ |
| Heine Lisa Wipperman | Director | A Award | 2022-01-03 | 2022-01-05 | 31,712 | — | $0 | 36,117 | SEC↗ |
| Barry John Joseph | Vice President of R&D | A Award deriv | 2021-10-01 | 2021-10-05 | 70,000 | — | $0 | 70,000 | SEC↗ |
| NIEBUR BRIAN | Chief Financial Officer | A Award deriv | 2021-10-01 | 2021-10-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Barry John Joseph | Vice President of R&D | A Award | 2021-10-01 | 2021-10-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NIEBUR BRIAN | Chief Financial Officer | A Award | 2021-10-01 | 2021-10-05 | 8,000 | — | $0 | 14,668 | SEC↗ |
| Ross Jeffrey James | CHIEF EXECUTIVE OFFICER | C Conversion deriv | 2021-06-28 | 2022-01-18 | 4,400 | — | $0 | 0 | SEC↗ |
| Ross Jeffrey James | CHIEF EXECUTIVE OFFICER | C Conversion | 2021-06-28 | 2022-01-18 | 4,400 | — | $0 | 208,150 | SEC↗ |
| Ross Jeffrey James | Chief Executive Officer | C Conversion deriv | 2021-06-28 | 2021-06-29 | 4,400 | — | $0 | 0 | SEC↗ |
| NIEBUR BRIAN | Chief Financial Officer | C Conversion deriv | 2021-06-28 | 2021-06-29 | 3,334 | — | $0 | 0 | SEC↗ |
| NIEBUR BRIAN | Chief Financial Officer | C Conversion deriv | 2021-06-28 | 2021-06-29 | 3,334 | — | $0 | 0 | SEC↗ |
| ERB JOHN L | Director | C Conversion deriv | 2021-06-28 | 2021-06-29 | 6,667 | — | $0 | 0 | SEC↗ |
| BUCKMAN PAUL | Director | C Conversion deriv | 2021-06-28 | 2021-06-29 | 3,000 | — | $0 | 0 | SEC↗ |
| WAGNER MARK T | Director | C Conversion deriv | 2021-06-28 | 2021-06-29 | 3,334 | — | $0 | 0 | SEC↗ |
| EIBENSTEINER RONALD E | Director | C Conversion deriv | 2021-06-28 | 2021-06-29 | 20,000 | — | $0 | 0 | SEC↗ |
| EIBENSTEINER RONALD E | Director | C Conversion deriv | 2021-06-28 | 2021-06-29 | 59,769 | — | $0 | 0 | SEC↗ |
| EIBENSTEINER RONALD E | Director | C Conversion deriv | 2021-06-28 | 2021-06-29 | 120,000 | — | $0 | 0 | SEC↗ |
| DAVITA INC. | 10% Owner | C Conversion deriv | 2021-06-28 | 2021-06-29 | 933,334 | — | $0 | 0 | SEC↗ |
| DAVITA INC. | 10% Owner | C Conversion deriv | 2021-06-28 | 2021-06-29 | 1,004,887 | — | $0 | 0 | SEC↗ |
| Ross Jeffrey James | Chief Executive Officer | C Conversion | 2021-06-28 | 2021-06-29 | 4,400 | — | $0 | 4,400 | SEC↗ |
| NIEBUR BRIAN | Chief Financial Officer | C Conversion | 2021-06-28 | 2021-06-29 | 3,334 | — | $0 | 3,334 | SEC↗ |
| NIEBUR BRIAN | Chief Financial Officer | C Conversion | 2021-06-28 | 2021-06-29 | 3,334 | — | $0 | 6,668 | SEC↗ |
| ERB JOHN L | Director | C Conversion | 2021-06-28 | 2021-06-29 | 6,667 | — | $0 | 12,222 | SEC↗ |
| BUCKMAN PAUL | Director | C Conversion | 2021-06-28 | 2021-06-29 | 3,000 | — | $0 | 8,555 | SEC↗ |
| WAGNER MARK T | Director | C Conversion | 2021-06-28 | 2021-06-29 | 3,334 | — | $0 | 3,334 | SEC↗ |
| EIBENSTEINER RONALD E | Director | C Conversion | 2021-06-28 | 2021-06-29 | 120,000 | — | $0 | 179,769 | SEC↗ |
| EIBENSTEINER RONALD E | Director | C Conversion | 2021-06-28 | 2021-06-29 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EIBENSTEINER RONALD E | Director | C Conversion | 2021-06-28 | 2021-06-29 | 59,769 | — | $0 | 59,769 | SEC↗ |
| DAVITA INC. | 10% Owner | C Conversion | 2021-06-28 | 2021-06-29 | 1,046,757 | — | $0 | 1,980,091 | SEC↗ |
| DAVITA INC. | 10% Owner | C Conversion | 2021-06-28 | 2021-06-29 | 933,334 | — | $0 | 933,334 | SEC↗ |
| BAXTER HEALTHCARE CORP | 10% Owner | C Conversion deriv | 2021-06-24 | 2021-06-25 | 2,083,333 | — | $0 | 0 | SEC↗ |
| BAXTER HEALTHCARE CORP | 10% Owner | C Conversion | 2021-06-24 | 2021-06-25 | 2,083,333 | — | $0 | 2,083,333 | SEC↗ |
| DAVITA INC. | 10% Owner | X Exercise deriv | 2021-06-23 | 2021-06-25 | 240,000 | — | $0 | 0 | SEC↗ |
| DAVITA INC. | 10% Owner | X Exercise deriv | 2021-06-23 | 2021-06-25 | 240,000 | — | $0 | 240,000 | SEC↗ |
| DAVITA INC. | 10% Owner | S Sale deriv | 2021-06-23 | 2021-06-25 | 192,000 | — | $0 | 48,000 | SEC↗ |
| DAVITA INC. | 10% Owner | X Exercise deriv | 2021-06-23 | 2021-06-25 | 956,887 | — | $0 | 0 | SEC↗ |
| DAVITA INC. | 10% Owner | X Exercise deriv | 2021-06-23 | 2021-06-25 | 0 | — | $0 | 1,004,887 | SEC↗ |
| ERB JOHN L | Director | A Award | 2021-06-23 | 2021-06-25 | 5,555 | — | $0 | 5,555 | SEC↗ |
| BUCKMAN PAUL | Director | A Award | 2021-06-23 | 2021-06-25 | 5,555 | — | $0 | 5,555 | SEC↗ |
| Maag Peter | Director | A Award | 2021-06-23 | 2021-06-25 | 5,555 | — | $0 | 5,555 | SEC↗ |
| Maag Peter | Director | A Award | 2021-06-23 | 2021-06-25 | 16,666 | — | $0 | 22,221 | SEC↗ |